| Title : The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease - Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16 |
| Author(s) : Bodick NC , Offen WW , Shannon HE , Satterwhite J , Lucas R , van Lier R , Paul SM |
| Ref : Alzheimer Disease & Associated Disorders , 11 Suppl 4 :S16 , 1997 |
| Abstract : Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16 |
| ESTHER : Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16 |
| PubMedSearch : Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16 |
| PubMedID: 9339268 |
Bodick NC, Offen WW, Shannon HE, Satterwhite J, Lucas R, van Lier R, Paul SM (1997)
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease
Alzheimer Disease & Associated Disorders
11 Suppl 4 :S16
Bodick NC, Offen WW, Shannon HE, Satterwhite J, Lucas R, van Lier R, Paul SM (1997)
Alzheimer Disease & Associated Disorders
11 Suppl 4 :S16